Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis and Management of Nonalcoholic Fatty Liver Disease.

Literature DB >> 30476962

Diagnosis and Management of Nonalcoholic Fatty Liver Disease.

Sonali Paul¹, Andrew M Davis¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 30476962 DOI： 10.1001/jama.2018.17365

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction.

Authors: Maolin Cao; Tingming Li; Zhifeng Li; Fang Gong; Zijun Chen
Journal: Exp Ther Med Date: 2022-08-31 Impact factor: 2.751

2. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.

Authors: Chenxi Wang; Zhensheng Cai; Xia Deng; Haoxiang Li; Zhicong Zhao; Chang Guo; Panpan Zhang; Lian Li; Tian Gu; Ling Yang; Li Zhao; Dong Wang; Guoyue Yuan
Journal: Int J Med Sci Date: 2021-07-23 Impact factor: 3.738

Review 3. [New aspects of nonalcoholic steatohepatitis].

Authors: N Stefan
Journal: Internist (Berl) Date: 2019-02 Impact factor: 0.743

4. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.

Authors: Andrew D Schreiner; Jingwen Zhang; Valerie Durkalski-Mauldin; Sherry Livingston; Justin Marsden; John Bian; Patrick D Mauldin; William P Moran; Don C Rockey
Journal: Diabetes Metab Res Rev Date: 2021-04-09 Impact factor: 4.876

5. Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress.

Authors: Wan-Jun Zhao; Yang-Ping Bian; Qiu-Hui Wang; Fei Yin; Li Yin; Yong-Lan Zhang; Jian-Hui Liu
Journal: Acta Pharmacol Sin Date: 2021-05-14 Impact factor: 6.150

6. ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation.

Authors: Di Lu; Qiaoyun Xia; Zhiyu Yang; Shanjun Gao; Suofeng Sun; Xiaoying Luo; Zhen Li; Xiulei Zhang; Shuangyin Han; Xiuling Li; Mingbo Cao
Journal: Ann Transl Med Date: 2021-04

Diagnosis and Management of Nonalcoholic Fatty Liver Disease.

1. A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction.

2. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.

Review 3. [New aspects of nonalcoholic steatohepatitis].

4. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.

5. Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress.

6. ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation.

Review 7. Lifestyle interventions for non-alcoholic fatty liver disease.

Review 8. COVID-19 and pediatric fatty liver disease: Is there interplay?

9. Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

10. Efficacy of Dietary Supplements to Reduce Liver Fat.